Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla.

Chaumeil MM, Gini B, Yang H, Iwanami A, Sukumar S, Ozawa T, Pieper RO, Mischel PS, James CD, Berger MS, Ronen SM.

Neuro Oncol. 2012 Aug;14(8):1050-61. doi: 10.1093/neuonc/nos126.

2.

Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of glioma.

Bennewitz MF, Tang KS, Markakis EA, Shapiro EM.

Mol Imaging Biol. 2012 Dec;14(6):676-87. doi: 10.1007/s11307-012-0553-3.

3.

Evaluation of intracellular labeling with micron-sized particles of iron oxide (MPIOs) as a general tool for in vitro and in vivo tracking of human stem and progenitor cells.

Boulland JL, Leung DS, Thuen M, Vik-Mo E, Joel M, Perreault MC, Langmoen IA, Haraldseth O, Glover JC.

Cell Transplant. 2012;21(8):1743-59. doi: 10.3727/096368911X627598.

PMID:
22490338
4.

Intracellular labeling of mouse embryonic stem cell-derived neural progenitor aggregates with micron-sized particles of iron oxide.

Sart S, Bejarano FC, Baird MA, Yan Y, Rosenberg JT, Ma T, Grant SC, Li Y.

Cytotherapy. 2015 Jan;17(1):98-111. doi: 10.1016/j.jcyt.2014.09.008.

PMID:
25527864
5.

Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.

Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF.

Cancer Res. 2005 Apr 15;65(8):3307-18. Erratum in: Cancer Res. 2006 Jun 1;66(11):5975.

6.

Imaging of human mesenchymal stromal cells: homing to human brain tumors.

Menon LG, Pratt J, Yang HW, Black PM, Sorensen GA, Carroll RS.

J Neurooncol. 2012 Apr;107(2):257-67. doi: 10.1007/s11060-011-0754-7.

PMID:
22081298
7.

Non-invasive longitudinal tracking of human amniotic fluid stem cells in the mouse heart.

Delo DM, Olson J, Baptista PM, D'Agostino RB Jr, Atala A, Zhu JM, Soker S.

Stem Cells Dev. 2008 Dec;17(6):1185-94. doi: 10.1089/scd.2008.0028.

8.

Magnetic resonance imaging assessment of macrophage accumulation in mouse brain after experimental traumatic brain injury.

Foley LM, Hitchens TK, Ho C, Janesko-Feldman KL, Melick JA, Bayir H, Kochanek PM.

J Neurotrauma. 2009 Sep;26(9):1509-19. doi: 10.1089/neu.2008.0747.

9.

EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma.

Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H.

Cancer Res. 2010 Aug 1;70(15):6303-12. doi: 10.1158/0008-5472.CAN-10-1022.

10.

In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model.

Chien LY, Hsiao JK, Hsu SC, Yao M, Lu CW, Liu HM, Chen YC, Yang CS, Huang DM.

Biomaterials. 2011 Apr;32(12):3275-84. doi: 10.1016/j.biomaterials.2011.01.042.

PMID:
21295344
12.

Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.

Sterenczak KA, Meier M, Glage S, Meyer M, Willenbrock S, Wefstaedt P, Dorsch M, Bullerdiek J, Murua Escobar H, Hedrich H, Nolte I.

BMC Cancer. 2012 Jul 11;12:284.

13.

In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles.

Rohani R, de Chickera SN, Willert C, Chen Y, Dekaban GA, Foster PJ.

Mol Imaging Biol. 2011 Aug;13(4):679-94. doi: 10.1007/s11307-010-0403-0.

PMID:
20803172
14.

The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.

Veeravagu A, Hou LC, Hsu AR, Cai W, Greve JM, Chen X, Tse V.

Neurol Res. 2008 Nov;30(9):952-9. doi: 10.1179/174313208X322761.

PMID:
18662497
15.
16.

In vivo MR imaging tracking of magnetic iron oxide nanoparticle labeled, engineered, autologous bone marrow mesenchymal stem cells following intra-articular injection.

Jing XH, Yang L, Duan XJ, Xie B, Chen W, Li Z, Tan HB.

Joint Bone Spine. 2008 Jul;75(4):432-8. doi: 10.1016/j.jbspin.2007.09.013.

PMID:
18448377
17.

In vivo MRI tracking of iron oxide nanoparticle-labeled human mesenchymal stem cells in limb ischemia.

Li XX, Li KA, Qin JB, Ye KC, Yang XR, Li WM, Xie QS, Jiang ME, Zhang GX, Lu XW.

Int J Nanomedicine. 2013;8:1063-73. doi: 10.2147/IJN.S42578.

18.

Dual-modal nanoprobes for imaging of mesenchymal stem cell transplant by MRI and fluorescence imaging.

Sung CK, Hong KA, Lin S, Lee Y, Cha J, Lee JK, Hong CP, Han BS, Jung SI, Kim SH, Yoon KS.

Korean J Radiol. 2009 Nov-Dec;10(6):613-22. doi: 10.3348/kjr.2009.10.6.613.

19.

In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution.

Kim SM, Jeong CH, Woo JS, Ryu CH, Lee JH, Jeun SS.

Int J Nanomedicine. 2015 Dec 18;11:13-23. doi: 10.2147/IJN.S97073.

20.

Multimodal imaging of micron-sized iron oxide particles following in vitro and in vivo uptake by stem cells: down to the nanometer scale.

Roose D, Leroux F, De Vocht N, Guglielmetti C, Pintelon I, Adriaensen D, Ponsaerts P, Van der Linden A, Bals S.

Contrast Media Mol Imaging. 2014 Nov-Dec;9(6):400-8. doi: 10.1002/cmmi.1594.

PMID:
24753446
Items per page

Supplemental Content

Support Center